Platforms and infrastructures

For further information about platforms and infrastructures, please contact: Manon Valiquette (manon.valiquette@umontreal.ca ; 514 343-6703).

For further information about the Drug discovery Unit, please contact: Madeleine Héroux (madeleine.heroux@umontreal.ca ; 514 343-6111, p. 30057).

  • ChemoGenix

    Human genome-wide CRISPR/Cas9 screening with access to the largest repertoire of chemogenomic signatures.

    For more information: https://chemogenix.iric.ca/

  • Drug Discovery Unit

    Conception, synthesis and discovery of new drugs

  • Proteomics

    Identification and quantification of proteins based on their chemical composition

  • Histology

    Preparation and observation of normal or tumor tissue in order to study their properties

  • Genomics

    Determining the genetic code and measuring gene expression

  • Flow Cytometry

    Sort and analysis of cell physical and molecular characteristics

  • Cytogenetics

    Chromosomal structure analysis of normal cells and cancer cells

  • High-throughput screening

    Robotic systems that can measure the effect of hundreds of thousands of molecules

  • Biophysics/NMR

    Molecular structure and interaction analysis using nuclear magnetic resonance (NMR)

  • Bioinformatics

    Complex computer analysis of a large volume of data generated by research

  • Bio-Imaging

    State-of-the-art microscopy for research

  • In Vivo Biology

    Study of biological mechanisms using rodent models